Clinical Trials Browser

Phase 2 × prexasertib × Head & Neck × Clear all

NCT06597565 2025-10-20

A Phase II Study of ACR-368 and Low Dose Gemcitabine in R/M HNSCC

Phase 2 Recruiting

Squamous Cell Carcinoma of Head and Neck